Objective: To predict symptomatic recurrence among community stone formers with one or more previous stone episodes. Patients and Methods: A random sample of incident symptomatic kidney stone formers in Olmsted County, Minnesota, was followed for all symptomatic stone episodes resulting in clinical care from January 1, 1984, through January 31, 2017. Clinical and radiographic characteristics at each stone episode predictive of subsequent episodes were identified. Results: There were 3364 incident kidney stone formers with 4951 episodes. The stone recurrence rates per 100 person-years were 3.4 (95% CI, 3.2-3.7) after the first episode, 7.1 (95% CI, 6.4-7.9) after the second episode, 12.1 (95% CI, 10.3-13.9) after the third episode, and 17.6 (95% CI, 15.1-20.0) after the fourth or higher episode (P<.001 for trend). A parsimonious model identified the following independent risk factors for recurrence: younger age; male sex; higher body mass index; family history of stones; pregnancy; incident asymptomatic stone on imaging before the first episode; suspected stone episode before the first episode; history of a brushite, struvite, or uric acid stone; no history of calcium oxalate monohydrate stone; kidney pelvic or lower pole stone on imaging; no ureterovesical junction stone on imaging; number of kidney stones on imaging; and diameter of the largest kidney stone on imaging. The model had a C-index corrected for optimism of 0.681 and was used to develop a prediction tool. The risk of recurrence in 5 years ranged from 0.9% to 94%, depending on risk factors, number of past episodes, and years since the last episode. Conclusion: The revised Recurrence Of Kidney Stone tool predicts the risk of symptomatic recurrence by using readily available clinical characteristics of stone formers.
S
ymptomatic recurrence with kidney stones can vary substantially between patients, with some having only an isolated episode while others having frequent recurrence that can be debilitating with chronic pain and numerous operations. There are dietary and medication interventions that can be used to help prevent kidney stone formation and growth, [1] [2] [3] but these interventions can be burdensome and costly and have potential adverse effects. Identifying patients who are at high or low risk of symptomatic recurrence can help inform decisions about lifetime commitment to various stone prevention interventions.
We previously developed the Recurrence Of Kidney Stone (ROKS) model (https:// www.qxmd.com/calculate/calculator_3/roksrecurrence-of-kidney-stone-2014) to predict the risk of a second symptomatic kidney stone episode after the first episode on the basis of 11 predictors. 4 However, this tool is not applicable for predicting recurrence in those who have had 2 or more symptomatic episodes. The relationship between the number of previous stone episodes and the risk of symptomatic recurrence is unclear in the general community. There is evidence that more past stone episodes predicts an increased risk of future episodes, 5, 6 but this has only been studied in specialty clinics.
We developed a revised ROKS tool to predict the risk of symptomatic recurrence after each stone episode in a populationbased cohort of symptomatic kidney stone formers. A total of 27 candidate predictors at the first and subsequent stone episodes, the number of past episodes, and the recurrence-free time interval since the last episode were evaluated to predict symptomatic recurrence. We also investigated 24 hour urine chemistries among the subset of patients with available laboratory measurements as predictors of recurrence. We further assessed the prevalence of dietary, medical, and surgical interventions with an increasing number of stone episodes and assessed any effect of these interventions on the risk of symptomatic recurrence.
PATIENTS AND METHODS

Study Sample
After institutional review board approval, adult residents of Olmsted County, Minnesota, with a first-time symptomatic kidney stone episode were followed for all recurrent symptomatic episodes in an expansion of a historical cohort study previously used to develop the initial ROKS tool. 4, 7 All data were obtained through the Rochester Epidemiology Project, a resource that provides access to medical records of nearly all medical institutions for residents of the county. 8 Residents with their first symptomatic kidney stone episode between January 1, 1984, and December 31, 2012, and with Minnesota Research Authorization 9 were identified using International Classification of Diseases, Ninth Revision codes 592, 594, and 274.11. Complete medical records (inpatient and outpatient) were reviewed in a random order by dedicated nurse abstractors between May 1, 2009, and January 31, 2017, under the supervision of nephrologists and urologists. All stone episodes were confirmed (validated) to be symptomatic with either a passed stone or a ureteral obstructing stone on imaging (see Supplemental Methods, available online at http://www. mayoclinicproceedings.org). Stone formers with at least 1 confirmed symptomatic stone episode underwent further review of their medical records for candidate predictors of recurrence.
Candidate Clinical Predictors
The following candidate predictors of symptomatic recurrence were defined at the time of the first symptomatic stone episode: sex, race (white vs nonwhite), family history of kidney stones (any documented blood relative), past incident (asymptomatic) kidney stone on imaging, and past suspected kidney stone episode (symptomatic but no seen stone). The following candidate predictors of symptomatic recurrence were updated at each episode: age, body mass index (BMI; calculated as the weight in kilograms divided by the height in meters squared), pregnancy, urinary tract infection, microscopic hematuria, gross hematuria, diarrhea, and lower urinary tract infection symptoms. The following candidate predictors of symptomatic recurrence were updated as to whether they ever occurred at or before each episode: any documented self-managed stone episode without clinical care, hypertension, diabetes mellitus, and each stone composition type (see Supplemental Methods).
Candidate Imaging Predictors
Imaging findings by computed tomography, excretory urography, abdominal radiography, or ultrasonography were updated at each stone episode. Radiographic reports were abstracted for these findings, with images reviewed only when reported findings were unclear. Imaging findings evaluated as predictors were number of stones in both kidneys (0, 1, or !2), number of stones in both ureters (0, 1, or !2), any kidney pelvic or lower pole stone, any ureteropelvic junction stone, any ureterovesical junction stone, diameter of the largest kidney stone (no stone or <3mm, 3-6mm, or >6mm), and diameter of the largest ureter stone (no stone or <3mm, 3-6mm, or >6mm).
Stone Prevention Interventions and Urine Chemistries
We identified stone prevention interventions at each stone episode, including recommended diet alterations (high-water, lowsodium, low-protein, or low-oxalate intake), medications prescribed specifically for stone prevention (thiazide diuretics, potassium citrate, or allopurinol), stone clinic evaluations (nephrology evaluation focused on stone prevention with blood and 24-hour urine chemistries), and surgical intervention (shock wave lithotripsy, ureteroscopic, ureteral stent, percutaneous, or open procedures to remove stones) for the symptomatic stone, in which asymptomatic stones may also have been removed. Any 24-hour urine volume and calcium, citrate, or oxalate levels in stone formers were also identified.
Statistical Analyses
Analyses were performed with R version 3.3.1 (R Foundation for Statistical Computing, www.R-project.org) using the survival and rms packages and with SAS 9.4 (SAS Institute Inc.). Multivariable penalized regression models to predict confirmed symptomatic recurrence that considered all the candidate predictors were developed using the least absolute shrinkage and selection operator model building approach (see Supplemental Methods). 10, 11 A revised ROKS tool based on the final statistical model was developed to predict the probability of symptomatic recurrence at 5 and 10 years after any number of previous episodes. Subsequently, stone prevention interventions and calendar year of stone episodes were individually considered as predictors of symptomatic recurrence after adjustment for predictors in the final model. In the subset with 24-hour urine chemistries, urine chemistries were also individually considered as predictors of symptomatic recurrence after adjustment for predictors in the final model.
RESULTS
Study Sample and Episode Rate
On the basis of International Classification of Diseases, Ninth Revision codes, a random sample of 6805 newly coded stone formers were identified among Olmsted County residents. After manual chart review, 3364 incident symptomatic adult stone formers without rare stone types who had 4951 stone episodes were identified ( Figure 1 ). The number of years of subsequent episodes, person-years of follow-up, and recurrence rate after each increasing number of stone episodes are listed in Table 1 . Beyond the fifth episode, the recurrence rate did not consistently increase and the number of stone formers with recurrent episodes became small (Table 1 ). The average stone recurrence rates per 100 person-years were 3.4 (95% CI, 3.2-3.7) after the first stone episode, 7.1 (95% CI, 6.4-7.9) after the second episode, 12.1 (95% CI, 10.3-13.9) after the third episode, and 17.6 (95% CI, 15.1-20.0) after the fourth or higher episode (P<.001 for trend) (Figure 2 ). 
Predictors for Subsequent Stone Episodes
After the First, Second, and Third Episodes The association of candidate predictors with a subsequent symptomatic stone episode after the first, second, and third episodes was assessed. These were divided into clinical characteristics defined at the first stone episode (Supplemental Table 1 , available online at http://www.mayoclinicproceedings. org), clinical characteristics updated at each episode (Supplemental Table 2 , available online at http://www.mayoclinicproceedings. org), and imaging findings updated at each episode (Supplemental Table 3 , available online at http://www.mayoclinicproceedings. org).
Multivariable Model
Of these 27 candidate predictors, 13 were chosen for the final model. The final model used all 4951 episodes, though imaging data were available for only 3699 episodes (the other stone episodes involved medical care without imaging). We could only fit a multivariable model that reported an increasing risk of recurrence with the number of past episodes by combining those with 4 or more episodes into one group (4þ). Hypertension was excluded from the model due to concerns it represented unmeasured thiazide diuretic use. Predictors of symptomatic recurrence selected for the final model were younger age, male sex, higher BMI, family history of stones, pregnancy, asymptomatic stone before the first episode, suspected stone before the first episode, history of a brushite, struvite, or uric acid stone, no history of a calcium oxalate monohydrate stone, pelvic or lower pole stone, no ureterovesical junction stone, number of kidney stones, and diameter of the largest kidney stone ( Table 2 ). The final model had a C-index of 0.687 (95% CI, 0.675-0.703); with bootstrapping, the C-index corrected for optimism was 0.681. As presented in Supplemental Table 4 (available online at http://www. mayoclinicproceedings.org), history of a brushite, struvite, or uric acid stone was the only predictor to differ between those with and without a kidney stone on imaging at their last episode; however, adding this interaction to the final model would have only modestly improved the C-index from 0.687 to 0.689.
Recurrence Of Kidney Stone Tool
The linear predictors derived from the final Cox regression model were used to develop the revised ROKS tool (https://qxcalc.app. Table 5 , available online at http://www. mayoclinicproceedings.org) depending on the number of the current episode, years since the last episode, and prediction of 5-year risk (Supplemental Figure 2A , available online at http://www.mayoclinicproceedings.org) or 10-year risk (Supplemental Figure 2B) . More risk factors for recurrence (total points) increased with the number of episodes (Supplemental Figure 3 , available online at http://www.mayoclinicproceedings.org). The estimated 5-year recurrence rates were 17% (95% CI, 14%-20%), 32% (95% CI, 26%-38%), 47% (95% CI, 36%-57%), and 60% (95% CI, 38%-74%) and the estimated 10-year recurrence rates were 28% (95% CI, 24%-32%), 45% (95% CI, 37%-51%), 67% (95% CI, 53%-77%), and 68% (95% CI, 43%-83%) after the first, second, third, and fourth or higher episodes, respectively. There was good agreement between predicted and actual recurrence rates (Supplemental Figure 4 , available online at http://www. mayoclinicproceedings.org). Recurrence risk increased with both more past episodes and more total points (Figure 3) . For individual patients, the risk of recurrence in the next 5 or 10 years could vary from 0.9% to 94%, depending on total points, number of episodes, and years since the last episode (see Supplemental Example Patients, available online at http://www. mayoclinicproceedings.org).
Stone Prevention Interventions and 24-Hour Urine Chemistries
Except for surgeries, the prevalence of stone prevention interventions increased with the number of stone episodes, but none were associated with subsequent recurrence after adjusting for the ROKS model predictors Characteristic renal colic attributed to a stone, but no stone seen on imaging or documented as voided in the medical record.
( Table 3) . When added to the final ROKS model, stone surgery only modestly improved the C-index from 0.687 to 0.688 (Supplemental Table 6 , available online at http://www.mayoclinicproceedings.org). Similarly, adding calendar year of the stone episode to the final ROKS model only modestly improved the C-index from 0.687 to 0.689. Twenty-fourehour urine chemistry was available at some time point in 33% of stone formers. Although lower urine volume and lower urine citrate levels were independently predictive of recurrence, addition of these tests to the final ROKS model in the subset with urine chemistries only modestly improved the C-index (Supplemental Table 7 , available online at http://www. mayoclinicproceedings.org).
DISCUSSION
We identified 13 readily available clinical and radiographic predictors of symptomatic recurrence among community stone formers with 1 or more past stone episodes. We then developed a revised ROKS prediction tool that uses these 13 independent predictors, number of past stone episodes, and years since the last stone episode to predict the 5-and 10-year risk of future stone episodes. The risk of symptomatic recurrence in the next 5 years for individual stone formers ranged from 0.9% to 94%, depending on clinical and radiographic risk factors, number of past stone episodes, and years since the last stone episode. The predictors of symptomatic recurrence in the final model either are risk factors for kidney stone formation and growth or reflect the actual kidney stone burden at the last episode. Several of the predictors have been previously discussed in the original ROKS tool. 4, 7 Using this revised ROKS tool, we also found that higher BMI and pregnancy at the last episode predict recurrence. Obesity is an established risk factor for kidney stones 12 that may increase the risk of recurrence via hypercalciuria 13 or via insulin resistance with lower urine pH and hypocitraturia. 14 Pregnancy has recently been identified as a risk factor for kidney stones, 15 possibly because of hypercalciuria during pregnancy. 16 We also added more granular radiographic predictors compared to the original ROKS model. 4 We found that any lower pole or pelvic kidney stone, number of kidney stones, and diameter of the largest kidney stone each independently predicts symptomatic recurrence. Lower pole stones may lead to future symptomatic episodes because they reflect previously detached stones (location from gravity), reflect stones that formed out of residual fragments from past stone surgeries, or reflect stones that are too tedious to remove during surgery on a ureteral stone. Both the size and the number of kidney stones are predictive of future symptomatic stone episodes in referral populations. [17] [18] [19] [20] Although the risk of symptomatic recurrence increased progressively with the number of kidney stones, there was a higher risk with a stone diameter of 3 to 6 mm than with a stone diameter of less than 3 mm or greater than 6 mm. This may be due to a higher likelihood of surgical removal of large stones. Indeed, 63% of episodes with a greater than 6-mm kidney stone underwent surgery as compared with only 39% with a 3-to 6-mm (largest) kidney stone or 29% with a less than 3-mm (largest) kidney stone.
One of the key findings of this analysis is that the number of past episodes increases the risk of future stone episodes, but only up to about the fifth episode in the unadjusted analysis and the fourth episode in the multivariable-adjusted analysis. With subsequent symptomatic recurrence, stone formers may learn to self-manage some of their episodes (trial of passage) without clinical care. Indeed, self-managed stone episodes without clinical care became more common with each subsequent confirmed stone episode. However, we could only develop a tool to model the risk of stone episodes that result in clinical care. Self-managed stone episodes without clinical care are often not documented in the medical record.
Clinical trials do report a higher rate of recurrence in single episode stone formers than in this community setting (6 episodes per 100 person-years vs 3 episodes per 100 person-years). 21 This may be due to clinical trials including symptomatic recurrence that is self-managed, including Adjusted for the 13 predictors in the final model (Table 2) .
asymptomatic recurrence by radiographic increases in stone burden, and selective enrollment of high-risk patients referred to stone specialists. Clinical trials and observational studies in referral populations have previously linked more kidney stone episodes to a higher risk of recurrence. 5, 6, 21 This study extends these findings to the community setting (avoiding selection bias) and adds detail on how the specific number of episodes increases the risk of symptomatic recurrence (rather than just one vs multiple).
We could not detect a protective effect of stone prevention interventions. Stone prevention interventions were increasingly used with more symptomatic recurrence. Thus, prevention interventions were themselves a marker of recurrence. Sustained lifetime commitment to prevention dietary interventions and medications may not occur in many patients, even though clinical trials report short-term benefits. 22, 23 Lower urine volume and lower urine citrate levels predicted symptomatic recurrence, but their contribution to model discrimination was too weak to justify their inclusion.
There were several potential limitations to this study. About 25% of stone episodes lacked imaging variables. This reflects the clinical reality that not all stone episodes are managed with imaging, especially if the patient voids the stone and symptoms resolve. Limiting the analysis to only episodes managed with imaging would have substantially underestimated the risk of symptomatic recurrence. Stone composition is unknown when stones are voided and lost; 39% of the cohort lacked any stone composition data. 7 Excluding patients missing stone composition data would have biased the model, as lower-risk patients are less likely to have had stone composition analysis. 7 The tool was developed in Olmsted County, which is similar to the Upper Midwest of the United States in that it is predominantly white, is more educated, and has a continental climate pattern. 24 External validation is needed. Imaging modalities and treatments have changed over the 33-year study period and will continue to change in the future. Nonetheless, determining the rate of multiple symptomatic stone episodes among incident community stone formers requires a study period across several decades. It is also reassuring that adding calendar year to the model had no substantive effect on the model fit. The Cindex of 0.681 for this revised ROKS tool was relatively low for a prediction tool, though an improvement over the 0.647 for the previous ROKS tool. 4 Future prospective studies may be needed to better identify predictors as well as to follow for stone passage episodes that are self-managed or asymptomatic.
CONCLUSION
This study identified novel risk factors for stone recurrence, including number of past stone episodes and years since the last episode. The revised ROKS prediction tool for estimating symptomatic recurrence risks can be used to guide the management of stone formers by individualizing prevention interventions on the basis of the risk of symptomatic recurrence. This tool can also be used to estimate symptomatic stone episode rates that result in clinical care for use in clinical trials on kidney stone prevention.
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